Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Recruiting Phase 2 Phase 3 Interventional Study
Esophageal Cancer Perioperative Analgesia NSAIDs Opioid Patient-controlled Analgesia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
102 (estimated)
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18-75 years; * Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ; * Informed consent. Exclusion Criteria: * Has a history of cholecystitis or urolithiasis within 3 months; * Has a history of atherothrombosis (peripheral a…
Contacts

zhu zhixiang

13311131231

zhuzhixiang2010@163.com

CONTACT